As of Feb 27
| -1.43 / -1.84%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 96.00, with a high estimate of 100.00 and a low estimate of 68.00. The median estimate represents a +25.56% increase from the last price of 76.46.
The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.